Desmopressin Market
This report contains market size and forecasts of Desmopressin in global, including the following ... Read More
Hydrate inhibitors are used in order to prevent the formation of gas hydrates at lower temperature and high pressure conditions. There are two types of hydrate inhibitors – thermodynamic inhibitors and low dosage hydrate inhibitors. Low dosage hydrate inhibitors are of two types – anti-agglomerate (AA) inhibitors and kinetic hydrate inhibitors (KHIs). They are mainly utilized in onshore and offshore operations in the oil and gas industry.
This report contains market size and forecasts of Low-Dosage Hydrate Inhibitors (LDHIs) in global, including the following market information:
Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Low-Dosage Hydrate Inhibitors (LDHIs) companies in 2021 (%)
The global Low-Dosage Hydrate Inhibitors (LDHIs) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Agglomerate (AA) Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Low-Dosage Hydrate Inhibitors (LDHIs) include Schlumberger, BHGE, Halliburton, Ecolab, BASF, Arkema, Ashland and Clariant, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Low-Dosage Hydrate Inhibitors (LDHIs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Low-Dosage Hydrate Inhibitors (LDHIs) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Segment Percentages, by Type, 2021 (%)
Anti-Agglomerate (AA) Inhibitors
Kinetic Hydrate Inhibitors (KHI)
Global Low-Dosage Hydrate Inhibitors (LDHIs) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Segment Percentages, by Application, 2021 (%)
Onshore
Offshore
Global Low-Dosage Hydrate Inhibitors (LDHIs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Low-Dosage Hydrate Inhibitors (LDHIs) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Low-Dosage Hydrate Inhibitors (LDHIs) revenues share in global market, 2021 (%)
Key companies Low-Dosage Hydrate Inhibitors (LDHIs) sales in global market, 2017-2022 (Estimated), (MT)
Key companies Low-Dosage Hydrate Inhibitors (LDHIs) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Schlumberger
BHGE
Halliburton
Ecolab
BASF
Arkema
Ashland
Clariant
This report contains market size and forecasts of Desmopressin in global, including the following ... Read More
Desmopressin Acetate is a synthetic analogue of the natural pituitary hormone 8-arginine vasopres ... Read More
These days, people has began to pay more attention to health and weight management due to the cha ... Read More
This report contains market size and forecasts of Alarelin in global, including the following mar ... Read More